Literature DB >> 16798039

Phenotypic variability of mitochondrial disease caused by a nuclear mutation in complex II.

Alistair T Pagnamenta1, Iain P Hargreaves, Andrew J Duncan, Jan-Willem Taanman, Simon J Heales, John M Land, Maria Bitner-Glindzicz, James V Leonard, Shamima Rahman.   

Abstract

We report a patient with relatively mild Leigh syndrome and mitochondrial respiratory chain complex II deficiency caused by a homozygous G555E mutation in the nuclear encoded flavoprotein subunit of succinate dehydrogenase. This mutation has previously been reported in a lethal-infantile presentation of complex II deficiency. Such marked phenotypic heterogeneity, although typical of heteroplasmic mutations in the mitochondrial genome, is unusual for nuclear mutations. Comparable activities and stability of mitochondrial respiratory chain enzymes were demonstrated in both patients, so other reasons for the phenotypic variability are considered.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16798039     DOI: 10.1016/j.ymgme.2006.05.003

Source DB:  PubMed          Journal:  Mol Genet Metab        ISSN: 1096-7192            Impact factor:   4.797


  16 in total

Review 1.  Physiological consequences of complex II inhibition for aging, disease, and the mKATP channel.

Authors:  Andrew P Wojtovich; C Owen Smith; Cole M Haynes; Keith W Nehrke; Paul S Brookes
Journal:  Biochim Biophys Acta       Date:  2013-01-02

Review 2.  Structural basis for malfunction in complex II.

Authors:  Tina M Iverson; Elena Maklashina; Gary Cecchini
Journal:  J Biol Chem       Date:  2012-08-17       Impact factor: 5.157

3.  The roles of SDHAF2 and dicarboxylate in covalent flavinylation of SDHA, the human complex II flavoprotein.

Authors:  Pankaj Sharma; Elena Maklashina; Gary Cecchini; T M Iverson
Journal:  Proc Natl Acad Sci U S A       Date:  2020-09-04       Impact factor: 11.205

4.  SDHA mutations causing a multisystem mitochondrial disease: novel mutations and genetic overlap with hereditary tumors.

Authors:  G Herma Renkema; Saskia B Wortmann; Roel J Smeets; Hanka Venselaar; Marion Antoine; Gepke Visser; Tawfeg Ben-Omran; Lambert P van den Heuvel; Henri J L M Timmers; Jan A Smeitink; Richard J T Rodenburg
Journal:  Eur J Hum Genet       Date:  2014-04-30       Impact factor: 4.246

5.  Familial neonatal isolated cardiomyopathy caused by a mutation in the flavoprotein subunit of succinate dehydrogenase.

Authors:  Aviva Levitas; Emad Muhammad; Gali Harel; Ann Saada; Vered Chalifa Caspi; Esther Manor; John C Beck; Val Sheffield; Ruti Parvari
Journal:  Eur J Hum Genet       Date:  2010-06-16       Impact factor: 4.246

6.  Progressive cerebellar atrophy in a patient with complex II and III deficiency and a novel deleterious variant in SDHA: A Counseling Conundrum.

Authors:  Beattie R H Sturrock; Ellen F Macnamara; Peter McGuire; Shannon Kruk; Ivan Yang; Jennifer Murphy; Cyndi J Tifft; Eliza Gordon-Lipkin
Journal:  Mol Genet Genomic Med       Date:  2021-05-07       Impact factor: 2.183

7.  SDHA loss of function mutations in a subset of young adult wild-type gastrointestinal stromal tumors.

Authors:  Antoine Italiano; Chun-Liang Chen; Yun-Shao Sung; Samuel Singer; Ronald P DeMatteo; Michael P LaQuaglia; Peter Besmer; Nicholas Socci; Cristina R Antonescu
Journal:  BMC Cancer       Date:  2012-09-14       Impact factor: 4.430

8.  Recessive germline SDHA and SDHB mutations causing leukodystrophy and isolated mitochondrial complex II deficiency.

Authors:  Charlotte L Alston; James E Davison; Francesca Meloni; Francois H van der Westhuizen; Langping He; Hue-Tran Hornig-Do; Andrew C Peet; Paul Gissen; Paola Goffrini; Ileana Ferrero; Evangeline Wassmer; Robert McFarland; Robert W Taylor
Journal:  J Med Genet       Date:  2012-09       Impact factor: 6.318

Review 9.  Recent advances in the genetics of SDH-related paraganglioma and pheochromocytoma.

Authors:  Erik F Hensen; Jean-Pierre Bayley
Journal:  Fam Cancer       Date:  2011-06       Impact factor: 2.375

10.  The mutations associated with dilated cardiomyopathy.

Authors:  Ruti Parvari; Aviva Levitas
Journal:  Biochem Res Int       Date:  2012-07-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.